XBiotech Inc
F:4XB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
XBiotech Inc
F:4XB
|
US |
|
W
|
Wesco International Inc
XMUN:WP7
|
US |
|
C
|
Commonwealth Bank of Australia
F:CWW
|
AU |
|
R
|
Rio Tinto PLC
OTC:RTPPF
|
UK |
|
V
|
Viserve Enterprise PCL
SET:VS
|
TH |
Intrinsic Value
Is 4XB undervalued or overvalued?
See the intrinsic value estimate for 
XBiotech Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
4XB looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with 4XB’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What XBiotech Does
XBiotech is a biotechnology company that develops antibody-based medicines, especially fully human monoclonal antibodies. Its work starts in the lab, where it identifies antibodies that can block disease pathways, and then it moves those candidates through testing and clinical trials. The company’s main goal is to turn those research programs into approved therapies for serious diseases such as cancer, inflammatory disorders, and infections.
- Headquarters
- United States of America US
- Employees
- 85
- IPO date
- Apr 15, 2015
Revenue & Expenses Breakdown
XBiotech Inc
Earnings Waterfall
XBiotech Inc
The intrinsic value for XBiotech Inc (4XB) under the Base Case is hidden EUR.
Compared with the current market price of 1.758 EUR, the stock appears hidden.